Benicar

This page contains recent news articles, when available, and an overview of Benicar but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Overview:

Benicar (when available)

Pharmacology and use:
Olmesartan Medoxomil, a specific angiotensin II antagonist, is used alone or with other antihypertensive agents to treat hypertension. Unlike the angiotensin receptor antagonist losartan, Olmesartan Medoxomil does not have an active metabolite or possess uricosuric effects. For the treatment of hypertension

Mechanism Of Action:
Olmesartan Medoxomil competes with angiotensin II for binding at the also stimulates the synthesis and release of aldosterone, blockage of its effects results in a decrease in systemic vascular resistance.

News Articles on Olmesartan Medoxomil

Generic Name: Olmesartan Medoxomil, Olmetec  -  ‎Nov 11, 2009‎
Benicar (generic name: Olmesartan, brand name: Olmetec) is a type of high blood pressure medicine called an angiotensin receptor blocker or ARB. ... Pattaya Daily News

Strong Yen Slows Japanese Drug Firms' Recovery  -  ‎Oct 30, 2009‎
...lifted by growing sales of its drug for high blood pressure, Benicar, also known as Olmetec, and contributions from Indian generic drug unit, ... Wall Street Journal

Forest Laboratories Inc. F2Q10 (Qtr End 30/09/09) Earnings Call Transcript  -  ‎Oct 20, 2009‎
The brand continues to add new prescribers and gain repeat prescribers at a rate higher than experienced with Benicar, at a similar time period post-launch, ... Seeking Alpha (blog)

Prescription Drugs: A 'Perfect Storm' That Almost Became a Killer  -  ‎Oct 29, 2009‎
There was Valium for the vertigo, antidepressant Trozodone to counteract insomnia, Diazide and Benicar for her high blood pressure, potassium tablets, ... ADVANCE

Forest Laboratories, Inc. Reports Fiscal Second Quarter 2010 Earnings Per ...  -  ‎Oct 20, 2009‎
Contract revenue increased 7.2% to $50.6 million, principally due to Benicar (olmesartan medoxomil) co-promotion income of $46.6 million, an increase of ... Reuters

Olmesartan medoxomil delayed microalbuminuria in patients with type 2 diabetes  -  ‎Nov 4, 2009‎
Patients were assigned to either once-daily olmesartan medoxomil 40 mg (n=2200; Benicar, Daiichi Sankyo) or placebo (n=2200) and were followed for 3.2 years ... Endocrine Today

Zacks Analyst Blog Highlights: Biogen Idec, Elan, UnitedHealth Group Inc ...  -  ‎Oct 22, 2009‎
Contract revenue, consisting primarily of Benicar co-promotion income, increased 7.2% to $50.6 million. Forest's most recent product launch, Savella, ... Business Wire (press release)

Daiichi Earns Win Against Mylan Over Benicar Patent  -  ‎Aug 4, 2009‎
Ltd.'s patent for the active ingredient in Benicar when Mylan tried to market a generic version of the hypertension drug. Judge William J. Martini of the US IP Law360 (subscription)

Biotech/Pharma Docket  -  ‎Aug 11, 2009‎
5616599, which covers the active ingredient of the hypertension drug Benicar®. Daiichi Sankyo originally filed suit in 2007, alleging that Mylan, Patent Docs

Daiichi wins patent battle  -  ‎Aug 3, 2009‎
US District Court in New Jersey has issued a decision in our US patent litigation against Mylan upholding the validity of our patent covering the Benicar, Hindu

Daiichi Wins Favorable Ruling in Patent Infringement Suit Against ...  -  ‎Aug 6, 2009‎
According to Daiichi Sankyo, olmesartan medoxomil, an active ingredient in Benicar, Benicar HCT and Azor, is an angiotensin II receptor antagonist that is istockAnalyst.com (press release)

Godrej buyout appetite  -  ‎Aug 3, 2009‎
The patent litigation was for the anti-hypertensive drug, Benicar. Mylan had filed an abbreviated new drug application seeking to market generic versions of Calcutta Telegraph

沙�?�类�?�物销售�?少70亿美元 �?�临被仿之痛  -  ‎Aug 4, 2009‎
...目�?，�?�有美�?�素和第一制�?�三共与森林实验室共�?�负责销售的奥美沙�?�酯（olmesartan medoxomil�?Benicar）这两�?��?�物还在愈�?�严峻的市场环境中努力守护自己的领地。中国食品商务网

沙�?�类�?�物研�?��?�滞专利到期�?70亿美元  -  ‎Aug 3, 2009‎
...目�?，�?�有美�?�素和第一制�?�三共与森林实验室共�?�负责销售的奥美沙�?�酯（olmesartanmedoxomil�?Benicar）这两�?��?�物还在愈�?�严峻的市场环境中努力守护自己的领地。慧聪网

Buy benicar. generic benicar pill  -  ‎Jul 1, 2009‎
Still looking for benicar? The best way is to visit our online store! We are in business for years, so shoping is 100% safe! Related Key: saturday delivery На плувка и дъно

Dr. Gott: Hives may be caused by infection  -  ‎Mar 28, 2009‎
He is currently taking Benicar, Toprol, simvastatin and a low-dose aspirin every day for cholesterol and blood pressure problems but is in good overall Northwest Herald

Forest Laboratories  -  ‎Mar 13, 2009‎
Products include Lexapro and Celexa, serotonin reuptake inhibitors for the treatment of major depression; Benicar, an angiotensin receptor blocker for the OneMedPlace

CEO likes to combine science, sales  -  ‎Mar 6, 2009‎
We combined our product Benicar, as it's known in the United States, with amlodipine, which is a different class of anti-hypertensive, into what we call a Trading Markets (press release)

SDI: Novartis Regains No. 1 Position with Managed Care Pharmacy ...  -  04 Feb 2009
Daiichi Sankyo’s Benicar was next with more than 70% of HMO members having access at a preferred position. Longitudinal patient data in SDI’s Vector One®: Business Wire (press release),

Daiichi Sankyo May Forecast Biggest Loss by Japanese Drugmaker  -  Jan 27, 2009
Daiichi Sankyo generated 22 percent of sales in the latest business year from Benicar, a pill against hypertension. Takeda Pharmaceutical Co. and Astellas Bloomberg

Daiichi Sankyo posts $3.7 bln Q3 loss on Ranbaxy  -  Jan 30, 2009
Revenues shrank 12 percent on a stronger yen and government-mandated price cuts, despite brisk sales globally of Benicar and other high-blood pressure guardian.co.uk,

Forest Laboratories, Inc. Reports Q3'09 Diluted Earnings Per Share ...  -  Jan 20, 2009
Also included in revenues was other income of $77942000 which includes contract revenue of $47283000 from the co-promotion of Benicar(R) (olmesartan PR Newswire (press release),

Waiting for Angioedema  -  Jan 19, 2009
He has a history of hypertension and has taken lisinopril and Benicar™ (olmesartan) for several years without recent dose titrations. EMS1.com - Emergency Medical Service Resources,

'올메�?', 아시아와 미국시장서 선전  -  Feb 1, 2009
2�?� 미래�?셋�?권�?� �?힌 �?료�? 따르면 3분기 누계실�?으로 '올메�?' 매출액�?� 유럽�?서만 전년�?�기대비 약 3.2% 가량 소�?� �?소한 반면 미국�?서 'Benicar'�?�는 메디파나뉴스,

Blood pressure medicine can cause hacking cough  -  Dec 22, 2008
Angiotensin receptor blockers such as Avapro, Benicar, Cozaar and Diovan are less likely to cause a chronic cough. My doctors were mystified by my anemia. Los Angeles Times,

Medicine triggers hallucinations  -  Dec 22, 2008
Angiotensin receptor blockers such as Avapro, Benicar, Cozaar and Diovan are less likely to cause a chronic cough. For more information about pros and cons Online Athens,

Daiichi Sankyo Submits Application for Approval of CS-866AZ ...  -  Dec 11, 2008
Ltd., and the high affinity AT1 subtype angiotensin II receptor antagonist olmesartan medoxomil (Olmetec®/Benicar®), developed by DAIICHI SANKYO. PharmaLive.com (press release),

High blood pressure doesn't slow Olympic swimmer  -  Dec 12, 2008
Today, he takes a white Benicar tablet each morning and evening. He'll probably take medication the rest of his life. He also sticks to a low-sodium diet. Austin 360,

It's not the economy, stupid  -  Nov 19, 2008
...vendor of patented drugs like Lexapro for depression (more than half of sales and growing), Namenda for Alzheimer's and Benicar for hypertension. Interactive Investor,

Daiichi Sankyo Completes Purchase of 63.9% of Ranbaxy (Update1)  -  Nov 6, 2008
Daiichi Sankyo, the maker of the Benicar hypertension medicine, is mimicking Novartis AG and Johnson & Johnson in diversifying as sales of branded products Bloomberg

Daiichi Sankyo Cuts Profit Forecast on Ranbaxy, R&D (Update2)  -  Oct 31, 2008
Sales rose 1.3 percent, led by the company's bestselling product, the high-blood-pressure pill Benicar. The Japanese company said it will include Ranbaxy's Bloomberg

Daiichi Sankyo Falls Most on Record Ahead of Meeting (Update1)  -  Oct 7, 2008
Daiichi Sankyo, which sells the Benicar hypertension drug, and its partner Eli Lilly & Co. are awaiting US approval to sell the experimental blood thinner Bloomberg

Forest Labs Sees Generic Threat  -  Sep 25, 2008
Principal brands include Lexapro for depression, Namenda for Alzheimer's disease, and Benicar for high blood pressure. The company turned in a very strong Trading Markets (press release),

Senior Dimensions Lowers Prescription Drug Co-Payments on Many ...  -  Sep 24, 2008
The more widely used maintenance drugs with reduced co-pays include: Avapro and Benicar, both used to treat hypertension; Actos and Lantus, used to treat MarketWatch

Zacks Analyst Blog Highlights: Forest Laboratories, Inc., CarMax ...  -  Sep 25, 2008
Principal brands include Lexapro for depression, Namenda for Alzheimer's disease and Benicar for high blood pressure. Forest has a number of other PR-Inside.com (Pressemitteilung),

Zacks Analyst Blog Highlights: Forest Laboratories, Inc., CarMax ...  -  Sep 25, 2008
Principal brands include Lexapro for depression, Namenda for Alzheimer's disease and Benicar for high blood pressure. Forest has a number of other Business Wire (press release),

CV Therapeutics Announces License Agreement for Ranexa(R) in ...  15 Sep 2008
...sitagliptin (Januvia(R)), esomeprazole (Nexium(R)), fluticasone/salmeterol (Advair(R)), nebivolol (Nebilet(R)) and olmesartan (Benicar(R)).PipelineReview.com (press release),

CV Therapeutics Announces License Agreement for Ranexa(R) in ...  Sep 12, 2008
...sitagliptin (Januvia(R)), esomeprazole (Nexium(R)), fluticasone/salmeterol (Advair(R)), nebivolol (Nebilet(R)) and olmesartan (Benicar(R)).Earthtimes (press release),

Indian Institute Defends Conduct of Clinical Trials  Aug 28, 2008
Two of the industry-sponsored trials were for Daiichi Sankyo’s Benicar (olmesartan medoxomil) and Novartis’ Diovan (valsartan), both hypertension drugs.FDA news (subscription),

Drug industry jobs disappearing in NJ  Aug 24, 2008
Sales for Daiichi Sankyo, which makes the blood pressure medication Benicar, increased 16 percent between 2006 and 2007 to exceed $1 billion, Salem said.New Brunswick Home News Tribune,

Forest 1Q profit falls 9 percent on Azor charge  -  Jul 22, 2008
Revenue from Benicar, which Forest promotes with Daiichi Sankyo, came in at $52.4 million, about even with the first quarter of fiscal 2008. CNNMoney.com

New Study Shows Benicar(R) (olmesartan medoxomil) Reverses Blood ...  -  Jun 19, 2008
...(2) Olmesartan medoxomil is marketed in the United States by Daiichi Sankyo, Inc. as Benicar(R). Benicar and Benicar HCT (olmesartan HispanicBusiness.com (press release),

New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood ...  -  Jun 16, 2008
BENICAR and BENICAR HCT(R) (olmesartan medoxomil/hydrochlorothiazide) are indicated for the treatment of hypertension. They may be used alone or in PR Newswire (press release),

Daiichi bags 2 patents for hypertension drug  -  Jun 16, 2008
The patents are for a key hypertension drug that sells under brand names Benicar and Benicar HCT or Olmitec and is one of its biggest money spinners Business Standard,

Daiichi to pay up to $4.6 billion for control of Ranbaxy  -  Jun 11, 2008
Shares in Daiichi Sankyo, best known for its high blood pressure medication Benicar and the experimental blood thinner prasugrel, ended nearly 5 percent Reuters

Exploring the ins and outs of blood pressure treatment  -  Jun 16, 2008
Two examples are Benicar and Diovan. The newest blood pressure medicine, Tekturna, has not been demonstrated to be a factor in ED, but it's so new that SouthCoastToday.com,

Mesotec Moves HQ From Germany to Green Tree  -  Jun 6, 2008
Daiichi, based in Tokyo, has already sued Mylan over its plan to sell a copy of Benicar, claiming it would violate the 2016 patent. RedOrbit,

Popular Drugs, Side-Effects and Feeling Ill  -  Jul 1, 2008
...as well as the Designer Drugs; angiotensin II receptor blockers (ARBs); Olmesartan (Benicar ) including candesartan (Atacand) and irbesartan (Avapro), Rocklin and Roseville Today,

Blood Pressure Medications Can Multi-Task  -  Jun 30, 2008
A newer group of drugs –but similar in action- came out and these “ARBs�? are known as Cozaar, Diovan, Avapro, Atacand and Micardis and Benicar. Best of Times,

Hypertension Treatment Effective In Reversing Vascular Damage ...  -  Jun 22, 2008
Olmesartan medoxomil is marketed in the United States as Benicar® and in Europe as Olmetec® by Daiichi Sankyo, Inc., which funded the study. Science Daily (press release)

New Study Shows BENICAR(R) (Olmesartan Medoxomil) Reverses Blood ...  -  Jun 16, 2008
BENICAR and BENICAR HCT(R) (olmesartan medoxomil/hydrochlorothiazide) are indicated for the treatment of hypertension. They may be used alone or in RedOrbit,

Japan's Daiichi Sankyo in 4.6 bin dlr takeover of India's Ranbaxy  -  Jun 11, 2008
Daiichi Sankyo -- best known for its high blood pressure medication Benicar -- is seen by analysts as having a solid number of new drugs in its development AFP

Drug may reverse vascular damage  -  Jun 18, 2008
Olmesartan medoxomil is marketed in the United States as Benicar and in Europe as Olmetec by Daiichi Sankyo Inc., which funded the study. United Press International

Russian Roulette, Generic Buyout  -  Jun 11, 2008
Ranbaxy, one of India’s largest companies, is a leading maker of generic drugs worldwide; Daiichi is best known for its blood-pressure drug Benicar. The Week Daily

Forest ends promotion of Daiichi hypertension drug  -  May 13, 2008
N: Quote, Profile, Research) Norvasc and Daiichi's Benicar, had won US approval in September. The companies had earlier struck a deal to co-promote Benicar. Reuters

New Data Shows 45 Percent of Patients With Stage 1 Hypertension ...  -  May 14, 2008
Eight out of 10 (cumulative 81%) patients with stage 1 hypertension were able to reach a goal blood pressure (BP) of < 140/90 mm Hg on BENICAR and BENICAR Earthtimes (press release),

Daiichi Sankyo 4th-Quarter Profit Rises on Blood Pressure Drugs  -  May 12, 2008
Shares of Daiichi Sankyo, which makes Benicar blood pressure pills, fell as much as 6.5 percent to 2670 yen after the earnings were announced at 1 pm They Bloomberg

Pharmacopeia's First-in-Class Investigational Therapy PS433540 ...  -  May 16, 2008
...(1) Prescribing Information for Coreg CR(R), Lotensin(R), Avapro(R), Benicar(R) and Norvasc(R) (2) American Heart Association news release. PR Newswire (press release),

Many Possible Routes to the Goal of 120/80  -  Apr 21, 2008
They include Diovan, Benicar and Avapro. Calcium channel blockers. Drugs like Norvasc, Procardia XL and DynaCirc CR help dilate blood vessels by preventing New York Times,

Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter ...  -  Apr 15, 2008
Sales of Namenda increased 26% to $829657000 from $660295000 while the earnings contribution from the Benicar co-promotion increased 22% to $212100000 from PR Newswire (press release),

Forest Labs Guides for 2009 Below Street  -  Apr 15, 2008
However, the company's co-promotion deal with partner Daiichi Sankyo for Benicar has expired, and there will be a gradual reduction in profit percentage on Houston Chronicle,

Forest Lab Swings To Profit In Q4; Sees FY09 Results Below Street ...  -  Apr 15, 2008
The company also predicts nearly 4% revenue growth for the year that includes product sales as well as the earnings contribution from Benicar, RTT News,

Forest backs pipeline as Lexapro and Namenda climb again  -  Apr 16, 2008
The antihypertensive Benicar (olmesartan medoxomil), which is co-promoted with Japan’s Daiichi Sankyo, brought in $58.2 million, an increase of 27%. Pharma Times (subscription),

Posted By Dr. Peter Gott  -  Apr 7, 2008
He is on Zetia, Benicar, Lipitor, aspirin and Effexor. His problem is that when he lies on his left side, he hears a pulsating blood-flow noise in his right Northern Daily News,

Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter ...  -  Apr 15, 2008
...earnings contribution of $58232000 from the co-promotion of Benicar(R) (olmesartan medoxomil) and Benicar HCT(R), antihypertensive therapies, Biloxi Sun Herald,

Forest Laboratories, Inc. Announces Amendment to Bystolic(TM ...  -  Feb 28, 2008
Azor is a trademark of Daiichi Sankyo, Inc.; Benicar and Benicar HCT are registered trademarks of Daiichi Sankyo, Inc.; and Campral is a registered FOXBusiness

Daiichi Sankyo Gains After Drug Gets Priority Review (Update6)  -  Feb 21, 2008
Daiichi jumped 4.2 percent as the Tokyo-based company moved closer to its first US release of an original drug since the Benicar blood-pressure pill in 2002 Bloomberg

Brand Names/Synonyms:
Benicar is also known by the following brand names and/or synonyms:
Benicar; CS 866; Olmesartan; Olmesartan Medoximil; Olmesartan Medoxomil; Olmetec

Drug Category:
Benicar is categorized under the following by the FDA: Antihypertensive Agents; ATC:C09CA08

Dosage Forms:
~13 hours

Absorption:
Bioavailability is about 26%

Interactions:
[an error occurred while processing this directive]

Chemical IUPAC Name:
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl5-(1-hydroxy-1-methyl-ethyl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-3H-imidazole-4-carboxylate

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.